Eisai promoted Lonnel Coats to president and CEO of Eisai Inc., from president and COO. In addition, Coats was appointed SVP of Eisai’s US pharmaceuticals business at Eisai’s Tokyo parent company, Eisai Co. Ltd., where he will have additional responsibility for leading Eisai’s global medical and marketing division. Coats will oversee all US operating companies, including Morphotek and Eisai Machinery USA, reporting directly to Haruo Naito, president and CEO of Eisai Co., Ltd. in Japan.